• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用多模式方法管理难治性内脏癌疼痛:一项病例研究。

Using a multimodal approach to manage difficult visceral cancer pain: A case study.

作者信息

Fernández Angélica, Rodríguez Cardona Ximena, Cardenas Rey Claudia Jimena, Moreno-Quijano Catalina, Rodriguez Martínez Carlos Hernán

机构信息

Pain Medicine and Palliative Care, Instituto Nacional de Cancerología, Universidad de la Sabana, Bogotá, Colombia.

Universidad Industrial de Santander, Bucaramanga, Colombia.

出版信息

SAGE Open Med Case Rep. 2023 Feb 28;11:2050313X231157483. doi: 10.1177/2050313X231157483. eCollection 2023.

DOI:10.1177/2050313X231157483
PMID:36890802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986897/
Abstract

Difficult visceral cancer pain is defined as pain that does not improve with conventional non-pharmacological and pharmacological strategies, including opioids and adjuvants, and occurs in up to 15% of patients with cancer. In oncological practice, we must be prepared to establish strategies for dealing with such complex cases. Different analgesic strategies have been described in the literature, including managing refractory pain through palliative sedation; however, this might become a dilemma from a clinical and bioethical point of view in end-of-life situations. We present the case of a young male patient with moderately differentiated intestinal-type adenocarcinoma of the left colon, with intra-abdominal sepsis, and for whom despite the multimodal treatment for difficult visceral cancer pain, the pain was refractory leading to palliative sedation. Difficult visceral cancer pain is a pathology that affects the quality of life of patients and is a challenge for pain specialists, for both pharmacological and non-pharmacological management.

摘要

难治性内脏癌痛被定义为采用包括阿片类药物和辅助药物在内的传统非药物和药物策略后疼痛仍未改善的疼痛,在高达15%的癌症患者中出现。在肿瘤学实践中,我们必须准备好制定应对此类复杂病例的策略。文献中描述了不同的镇痛策略,包括通过姑息性镇静来处理难治性疼痛;然而,从临床和生物伦理学角度来看,在临终情况下这可能会成为一个两难困境。我们报告了一例年轻男性患者,患有左半结肠中分化肠型腺癌并伴有腹腔内感染,尽管对难治性内脏癌痛进行了多模式治疗,但疼痛仍难以控制,最终导致了姑息性镇静。难治性内脏癌痛是一种影响患者生活质量且对疼痛专家在药物和非药物管理方面都构成挑战的病症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/692c2332ed3f/10.1177_2050313X231157483-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/7c4be01122ba/10.1177_2050313X231157483-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/df6a1394d1fd/10.1177_2050313X231157483-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/8fd2c219509e/10.1177_2050313X231157483-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/692c2332ed3f/10.1177_2050313X231157483-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/7c4be01122ba/10.1177_2050313X231157483-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/df6a1394d1fd/10.1177_2050313X231157483-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/8fd2c219509e/10.1177_2050313X231157483-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babd/9986897/692c2332ed3f/10.1177_2050313X231157483-fig4.jpg

相似文献

1
Using a multimodal approach to manage difficult visceral cancer pain: A case study.采用多模式方法管理难治性内脏癌疼痛:一项病例研究。
SAGE Open Med Case Rep. 2023 Feb 28;11:2050313X231157483. doi: 10.1177/2050313X231157483. eCollection 2023.
2
3
Pain and symptom control in paediatric palliative care.儿童姑息治疗中的疼痛和症状控制
Cancer Surv. 1994;21:211-31.
4
Successful Control of Pain from Malignant Psoas Syndrome by Spinal Opioid with Local Anesthetic Agents.阿片类药物联合局麻药椎管内给药成功控制恶性腰肌综合征疼痛
Pain Pract. 2018 Jun;18(5):641-646. doi: 10.1111/papr.12643. Epub 2017 Nov 20.
5
The current clinical use of adjuvant analgesics for refractory cancer pain in Japan: a nationwide cross-sectional survey.目前日本对难治性癌症疼痛辅助镇痛剂的临床应用:一项全国性的横断面调查。
Jpn J Clin Oncol. 2020 Dec 16;50(12):1434-1441. doi: 10.1093/jjco/hyaa147.
6
Cancer pain management. Current strategy.
Cancer. 1993 Dec 1;72(11 Suppl):3393-415. doi: 10.1002/1097-0142(19931201)72:11+<3393::aid-cncr2820721606>3.0.co;2-o.
7
Effectiveness of Low-Dose Ketamine Infusion in Opioid Refractory Cancer Pain: A Case Report.小剂量氯胺酮输注治疗阿片类药物难治性癌痛的有效性:一例报告
Cureus. 2022 Nov 18;14(11):e31662. doi: 10.7759/cureus.31662. eCollection 2022 Nov.
8
Topical Ketamine with Other Adjuvants: Underutilized for Refractory Cancer Pain? A Case Series and Suggested Revision of the World Health Organization Stepladder for Cancer Pain.局部用氯胺酮联合其他佐剂治疗难治性癌痛:是否未充分利用?一个病例系列及对世界卫生组织癌痛阶梯治疗方案的修订建议。
J Palliat Med. 2020 Sep;23(9):1167-1171. doi: 10.1089/jpm.2019.0618. Epub 2020 Mar 11.
9
Opioid and adjuvant analgesics: compared and contrasted.阿片类和辅助镇痛药:比较与对比
Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26.
10
Pharmacotherapy of pain in cancer patients - recommendations of the Polish Association for the Study of Pain, Polish Society of Palliative Medicine, Polish Society of Oncology, Polish Society of Family Medicine, Polish Society of Anaesthesiology and Intensive Therapy and Association of Polish Surgeons.癌症患者疼痛的药物治疗——波兰疼痛研究协会、波兰姑息医学学会、波兰肿瘤学会、波兰家庭医学学会、波兰麻醉学与重症治疗学会以及波兰外科医生协会的建议
Pol Przegl Chir. 2018 Aug 31;90(4):55-84. doi: 10.5604/01.3001.0012.2904.

引用本文的文献

1
Cancer pain: molecular mechanisms and management.癌症疼痛:分子机制与管理
Mol Biomed. 2025 Jun 28;6(1):45. doi: 10.1186/s43556-025-00289-0.

本文引用的文献

1
Chronic Pain: A Complex Condition With a Multi-Tangential Approach.慢性疼痛:一种需要多方面应对的复杂病症。
Cureus. 2021 Nov 23;13(11):e19850. doi: 10.7759/cureus.19850. eCollection 2021 Nov.
2
A 20-year study of the bidirectional relationship between anxious and depressive symptomology and pain medication usage.
Pain Manag. 2020 Jan;10(1):13-22. doi: 10.2217/pmt-2019-0037. Epub 2020 Jan 30.
3
Principles of cancer pain management: An overview and focus on pharmacological and interventional strategies.癌症疼痛管理原则:概述及药物和介入策略重点。
Aust J Gen Pract. 2018 Nov;47(11):758-762. doi: 10.31128/AJGP-07-18-4629.
4
Lidocaine for Cancer Pain in Adults: A Systematic Review and Meta-Analysis.利多卡因治疗成人癌痛的系统评价和 Meta 分析。
J Palliat Med. 2019 Mar;22(3):326-334. doi: 10.1089/jpm.2018.0257. Epub 2019 Jan 7.
5
Optimizing cancer pain management in resource-limited settings.优化资源有限环境下的癌症疼痛管理。
Support Care Cancer. 2019 Jun;27(6):2113-2124. doi: 10.1007/s00520-018-4471-z. Epub 2018 Sep 21.
6
Management of nausea and vomiting in patients with advanced cancer at the end of life.终末期晚期癌症患者恶心呕吐的管理
Nurs Stand. 2017 Nov 1;32(10):53-63. doi: 10.7748/ns.2017.e10993.
7
Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology
.慢性和难治性疼痛:肿瘤学药物治疗的系统评价
Clin J Oncol Nurs. 2017 Jun 1;21(3 Suppl):31-53. doi: 10.1188/17.CJON.S3.31-53.
8
Ketamine Protocol for Palliative Care in Cancer Patients With Refractory Pain.用于难治性疼痛癌症患者姑息治疗的氯胺酮方案
J Adv Pract Oncol. 2015 Nov-Dec;6(6):555-61. Epub 2015 Nov 1.
9
Novel nervous system mechanisms in visceral pain.内脏痛中的新型神经系统机制。
Neurogastroenterol Motil. 2016 Mar;28(3):309-15. doi: 10.1111/nmo.12785.
10
Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: a randomized study.阿片类药物轮换与联合用药治疗慢性疼痛控制不佳的癌症患者:一项随机研究。
BMC Palliat Care. 2015 Sep 16;14:41. doi: 10.1186/s12904-015-0038-7.